Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189 · see citing works

Oxyl radicals, redox-sensitive signalling cascades and antioxidants

Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930 · see citing works

Diabetic Kidney Disease: Challenges, Progress, and Possibilities

Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11491116 · Cited by 2,898 · see citing works

Dynamics and functions of lipid droplets

Olzmann, J. A., & Carvalho, P. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0085-z · Cited by 2,740 · see citing works

The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease

Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470 · see citing works

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · see citing works

Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development

Kang, H. M., Ahn, S. H., Choi, P., Ko, Y.-A., Han, S. H., Chinga, F., Park, A. S. D., Tao, J., Sharma, K., Pullman, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3762 · Cited by 1,555 · see citing works

Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes

Cnop, M., Welsh, N., Jonas, J.-C., Jörns, A., Lenzen, S., & Eizirik, D. L. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s97 · Cited by 1,491 · see citing works

Mitochondrial energetics in the kidney

Bhargava, P., & Schnellmann, R. G. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.107 · Cited by 1,363 · see citing works

Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity

Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · see citing works

Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study

Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · see citing works

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

Lean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 981 · see citing works

Inflammation and Lipid Signaling in the Etiology of Insulin Resistance

Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 942 · see citing works

Fatty acids, obesity, and insulin resistance: Time for a reevaluation

Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · see citing works

Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.

Perseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1600 · Cited by 877 · see citing works

The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease

Utzschneider, K. M., & Kahn, S. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0587 · Cited by 858 · see citing works

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome

Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820 · see citing works

Lipid Droplet Biogenesis

Walther, T. C., Chung, J., & Farese, R. V. (2017) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060608 · Cited by 772 · see citing works

Foam cells in atherosclerosis

Yu, X.-H., Fu, Y., Zhang, D., Yin, K., & Tang, C. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.06.006 · Cited by 772 · see citing works

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757 · see citing works

Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes

Birkenfeld, A. L., & Shulman, G. I. (2013) · Hepatology · doi:10.1002/hep.26672 · Cited by 740 · see citing works

Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis

D’Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman‐Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 726 · see citing works

Primary Membranous Nephropathy

Couser, W. G. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11761116 · Cited by 692 · see citing works

Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy

Herman‐Edelstein, M., Scherzer, P., Tobar, A., Levi, M., & Gafter, U. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p040501 · Cited by 652 · see citing works

Mitochondrial dysfunction in diabetic kidney disease

Forbes, J. M., & Thorburn, D. R. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.9 · Cited by 641 · see citing works

Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms

Guo, S. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0327 · Cited by 625 · see citing works

Mitochondria Bound to Lipid Droplets Have Unique Bioenergetics, Composition, and Dynamics that Support Lipid Droplet Expansion

Benador, I. Y., Veliova, M., Mahdaviani, K., Petcherski, A., Wikström, J. D., Assali, E. A., Acín‐Pérez, R., Shum, M., de Oliveira, M. F., Cinti, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.003 · Cited by 621 · see citing works

Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations

Milić, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9330 · Cited by 595 · see citing works

Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo

Wang, X., Collins, H. L., Ranalletta, M., Fuki, I. V., Billheimer, J. T., Rothblat, G. H., Tall, A. R., & Rader, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32057 · Cited by 593 · see citing works

Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease

Mota, M., Banini, B. A., Cazanave, S. C., & Sanyal, A. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.014 · Cited by 570 · see citing works

Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases

Choi, H. M., Doss, H. M., & Kim, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041219 · Cited by 520 · see citing works

Vascular endothelial growth factor B controls endothelial fatty acid uptake

Hagberg, C. E., Falkevall, A., Wang, X., Larsson, E., Huusko, J., Nilsson, I., van Meeteren, L. A., Samén, E., Lu, L., Vanwildemeersch, M., et al. (2010) · Nature · doi:10.1038/nature08945 · Cited by 514 · see citing works

Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease

de Vries, A. P. J., Ruggenenti, P. L., Ruan, X. Z., Praga, M., Cruzado, J. M., Bajema, I. M., D’Agati, V. D., Lamb, H. J., Barlovič, D. P., Hojs, R., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70065-8 · Cited by 503 · see citing works

The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction

Chevalier, R. L. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00164.2016 · Cited by 486 · see citing works

Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment

Ertunc, M. E., & Hotamışlıgil, G. S. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066514 · Cited by 485 · see citing works

Balancing the fat: lipid droplets and human disease

Krahmer, N., Farese, R. V., & Walther, T. C. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201100671 · Cited by 477 · see citing works

The impact of insulin resistance on the kidney and vasculature

Artunç, F., Schleicher, E. D., Weigert, C., Fritsche, A., Stefan, N., & Häring, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.145 · Cited by 474 · see citing works

Lipid Accumulation and Chronic Kidney Disease

Gai, Z., Wang, T., Visentin, M., Kullak-Ublick, G. A., Fu, X., & Wang, Z. (2019) · Nutrients · doi:10.3390/nu11040722 · Cited by 431 · see citing works

Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans

Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., Jelenik, T., Müller, J., Herder, C., Nowotny, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409229111 · Cited by 415 · see citing works

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG outcome randomised, placebo-controlled trial

Cherney, D. Z. I., Zinman, B., Inzucchi, S. E., Koitka-Weber, A., Mattheus, M., von Eynatten, M., & Wanner, C. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30182-1 · Cited by 383 · see citing works

NF-κB in inflammation and renal diseases

Zhang, H., & Sun, S.-C. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0056-4 · Cited by 383 · see citing works

Glucose handling by the kidney

Mather, A., & Pollock, C. A. (2011) · Kidney International · doi:10.1038/ki.2010.509 · Cited by 376 · see citing works

Roles of diacylglycerols and ceramides in hepatic insulin resistance

Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373 · see citing works

Lipotoxicity

Weinberg, J. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001834 · Cited by 372 · see citing works

Renal lipid metabolism and lipotoxicity

Bobulescu, I. A. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32833aa4ac · Cited by 366 · see citing works

Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial

Kahl, S., Gancheva, S., Straßburger, K., Herder, C., Machann, J., Katsuyama, H., Kabisch, S., Henkel, E., Kopf, S., Lagerpusch, M., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0641 · Cited by 360 · see citing works

Fatty Kidney, Hypertension, and Chronic Kidney Disease: The Framingham Heart Study

Foster, M. C., Hwang, S.-J., Porter, S. A., Massaro, J. M., Hoffmann, U., & Fox, C. S. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175315 · Cited by 356 · see citing works

SGLT2 Inhibitors and the Diabetic Kidney

Fioretto, P., Zambon, A., Rossato, M., Busetto, L., & Vettor, R. (2016) · Diabetes Care · doi:10.2337/dcs15-3006 · Cited by 348 · see citing works

Increasing Body Mass Index and Obesity in the Incident ESRD Population

Kramer, H., Saranathan, A., Luke, A., Durazo-Arvizú, R., Cao, G., Hou, S., & Cooper, R. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111241 · Cited by 345 · see citing works

Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms

Gnudi, L., Coward, R. J., & Long, D. A. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.07.002 · Cited by 333 · see citing works

European Association for the Study of the Liver ( EASL ), European Association for the Study of Diabetes ( EASD ) and European Association for the Study of Obesity ( EASO ) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes

Sberna, A.-L., Bouillet, B., Rouland, A., Brindisi, M., Nguyen, A., Mouillot, T., Duvillard, L., Denimal, D., Loffroy, R., Vergès, B. L., et al. (2017) · Diabetic Medicine · doi:10.1111/dme.13565 · Cited by 322 · see citing works

AMPK-Mediated Regulation of Lipid Metabolism by Phosphorylation

Wang, Q., Liu, S., Zhai, A., Zhang, B., & Tian, G. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00724 · Cited by 315 · see citing works

Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria

White, K., Bilous, R. W., Marshall, S. M., Nahas, M. E., Remuzzi, G., Piras, G., Cosmo, S. D., Viberti, G. C., & (ESPRIT), O. B. O. T. E. S. F. T. P. O. R. D. I. T. 1. D. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3083 · Cited by 313 · see citing works

Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice

Kim, M. Y., Lim, J. H., Youn, H. H., Hong, Y. A., Yang, K. S., Park, H., Chung, S., Koh, S. H., Shin, S. J., Choi, B. S., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2747-2 · Cited by 313 · see citing works

Fatty Acid-Induced Lipotoxicity in Pancreatic Beta-Cells During Development of Type 2 Diabetes

Oh, Y. S., Bae, G. D., Baek, D. J., Park, E., & Jun, H. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00384 · Cited by 307 · see citing works

SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy

Wang, X. X., Levi, J., Luo, Y., Myakala, K., Herman‐Edelstein, M., Qiu, L., Wang, D., Peng, Y., Grenz, A., Lucia, S. M., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.779520 · Cited by 307 · see citing works

Regulation of Renal Fatty Acid and Cholesterol Metabolism, Inflammation, and Fibrosis in Akita and OVE26 Mice With Type 1 Diabetes

Proctor, G., Jiang, T., Iwahashi, M., Wang, Z., Li, J., & Levi, M. (2006) · Diabetes · doi:10.2337/db05-0603 · Cited by 303 · see citing works

Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization

Glatz, J. F. C., & Luiken, J. J. F. P. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r082933 · Cited by 301 · see citing works

Understanding the mechanisms of reversal of type 2 diabetes

Taylor, R., Al-Mrabeh, A., & Sattar, N. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30076-2 · Cited by 299 · see citing works

Diabetic nephropathy: diagnosis and treatment

Fineberg, D., Jandeleit-Dahm, K. A. M., & Cooper, M. E. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.184 · Cited by 295 · see citing works

Protection of mitochondria prevents high-fat diet–induced glomerulopathy and proximal tubular injury

Szeto, H. H., Liu, S., Soong, Y., Alam, N., Prusky, G. T., & Seshan, S. V. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.013 · Cited by 293 · see citing works

A concise review of non-alcoholic fatty liver disease

Than, N. N., & Newsome, P. N. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.001 · Cited by 289 · see citing works

Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes

Hagberg, C. E., Mehlem, A., Falkevall, A., Muhl, L., Fam, B. C., Ortsäter, H., Scotney, P. D., Nyqvist, D., Samén, E., Li, L., et al. (2012) · Nature · doi:10.1038/nature11464 · Cited by 286 · see citing works

CD36 in chronic kidney disease: novel insights and therapeutic opportunities

Yang, X., Okamura, D. M., Lu, X., Chen, Y., Moorhead, J. F., Varghese, Z., & Ruan, X. Z. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.126 · Cited by 264 · see citing works

Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?

Higgins, G. C., & Coughlan, M. T. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12503 · Cited by 251 · see citing works

Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences

Vaziri, N. D. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.026 · Cited by 248 · see citing works

Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles

Verderio, C., Gabrielli, M., & Giussani, P. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r083915 · Cited by 237 · see citing works

Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid Accumulation

Wang, C., Pan, Y., Zhang, Q.-Y., Wang, F., & Kong, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038285 · Cited by 233 · see citing works

The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study

Charles, M.-A. A., Eschwège, É., Thibult, N., Claude, J., Warnet, J., Rosselin, G., Girard, J. R., & Balkau, B. (1997) · Diabetologia · doi:10.1007/s001250050793 · Cited by 231 · see citing works

The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes

Kim, Y., Lim, J. H., Kim, M. Y., Kim, E. N., Yoon, H. E., Shin, S. J., Choi, B. S., Kim, Y.-S., Chang, Y. S., & Park, C. W. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017060627 · Cited by 229 · see citing works

Lipids, lysosomes, and autophagy

Jaishy, B. P., & Abel, E. D. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067520 · Cited by 229 · see citing works

Tissue-specific Ablation of the GLUT4 Glucose Transporter or the Insulin Receptor Challenges Assumptions about Insulin Action and Glucose Homeostasis

Minokoshi, Y., Kahn, C. R., & Kahn, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300019200 · Cited by 219 · see citing works

Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes

Meex, R. C. R., Blaak, E. E., & van Loon, L. J. C. (2019) · Obesity Reviews · doi:10.1111/obr.12862 · Cited by 218 · see citing works

Decoding Insulin Resistance and Metabolic Syndrome for Promising Therapeutic Intervention

Guo, S. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0584 · Cited by 215 · see citing works

Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction

Qin, X., Zhao, Y. S., Gong, J., Huang, W., Su, H., Yuan, F., Fang, K., Wang, D., Li, J., Zou, X., et al. (2019) · Theranostics · doi:10.7150/thno.30640 · Cited by 213 · see citing works

Mitochondrial dysfunction in diabetic kidney disease

Wei, P. Z., & Szeto, C. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.005 · Cited by 207 · see citing works

Molecular Mechanism of Cyclodextrin Mediated Cholesterol Extraction

López, C. A., de Vries, A. H., & Marrink, ‪. J. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002020 · Cited by 197 · see citing works

Impact of different ectopic fat depots on cardiovascular and metabolic diseases

Ferrara, D., Montecucco, F., Dallegri, F., & Carbone, F. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28821 · Cited by 195 · cited 2× · see citing works

Exercise Induced Adipokine Changes and the Metabolic Syndrome

Golbidi, S., & Laher, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/726861 · Cited by 194 · see citing works

Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy

Hirayama, A., Nakashima, E., Sugimoto, M., Akiyama, S.-I., Sato, W., Maruyama, S., Matsuo, S., Tomita, M., Yuzawa, Y., & Soga, T. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6412-x · Cited by 191 · see citing works

Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis

Tanaka, Y., Kume, S., Araki, S., Isshiki, K., Chin‒Kanasaki, M., Sakaguchi, M., Sugimoto, T., Koya, D., Haneda, M., Kashiwagi, A., et al. (2011) · Kidney International · doi:10.1038/ki.2010.530 · Cited by 190 · see citing works

Dyslipidemia in patients with chronic kidney disease

Hager, M., Narla, A. D., & Tannock, L. R. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9402-z · Cited by 188 · see citing works

Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD

Afshinnia, F., Rajendiran, T. M., Soni, T., Byun, J., Wernisch, S., Sas, K. M., Hawkins, J. J., Bellovich, K. A., Gipson, D., Michailidis, G. C., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030350 · Cited by 187 · see citing works

Lipid droplet proteins and metabolic diseases

Xu, S., Zhang, X., & Liu, P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.019 · Cited by 185 · see citing works

Untitled work

(2009) · PubMed · Cited by 183 · see citing works

Therapeutic Landscape for NAFLD in 2020

Neuschwander‐Tetri, B. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.051 · Cited by 183 · see citing works

Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease

Falkevall, A., Mehlem, A., Palombo, I., Sahlgren, B. H., Ebarasi, L., He, L., Ytterberg, A. J., Olauson, H., Axelsson, J., Sundelin, B., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.01.004 · Cited by 179 · see citing works

ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes

Ducasa, G. M., Mitrofanova, A. V., Mallela, S. K., Liu, X., Molina, J., Sloan, A. J., Pedigo, C. E., Ge, M., Santos, J. V., Hernandez, Y., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125316 · Cited by 177 · see citing works

Interactions between kidney disease and diabetes: dangerous liaisons

Pecoits‐Filho, R., Abensur, H., Betônico, C. D. C. R., Machado, A. D., Parente, E. B., Queiroz, M. S., Salles, J. E. N., Titan, S., & Vencio, S. A. C. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0159-z · Cited by 174 · see citing works

Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction

Nishi, H., Higashihara, T., & Inagi, R. (2019) · Nutrients · doi:10.3390/nu11071664 · Cited by 174 · see citing works

SGLT2 inhibition and kidney protection

Nespoux, J., & Vallon, V. (2018) · Clinical Science · doi:10.1042/cs20171298 · Cited by 172 · see citing works

Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases

Jang, H., Noh, M. R., Kim, J., & Padanilam, B. J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00065 · Cited by 170 · see citing works

Sodium–glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice

Tanaka, S., Sugiura, Y., Saito, H., Sugahara, M., Higashijima, Y., Yamaguchi, J., Inagi, R., Suematsu, M., Nangaku, M., & Tanaka, T. (2018) · Kidney International · doi:10.1016/j.kint.2018.04.025 · Cited by 167 · see citing works

APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD

Freedman, B. I., Limou, S., Ma, L., & Kopp, J. B. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.020 · Cited by 163 · see citing works

Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities

Musso, G., Cassader, M., Cohney, S. J., Michieli, F. D., Pinach, S., Saba, F., & Gambino, R. (2016) · Diabetes Care · doi:10.2337/dc15-1182 · Cited by 162 · see citing works

Celastrol, an NF-κB Inhibitor, Improves Insulin Resistance and Attenuates Renal Injury in db/db Mice

Kim, J. E., Lee, M., Nam, D. H., Song, H. K., Kang, Y. S., Lee, J. E., Kim, H. W., Joo, J., Hyun, Y. Y., Han, S. Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062068 · Cited by 160 · see citing works

Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study

Leehey, D. J., Moinuddin, I., Bast, J. P., Qureshi, S., Jelinek, C. S., Cooper, C., Edwards, L. C., Smith, B. M., & Collins, E. G. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-62 · Cited by 156 · see citing works

Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.

Pedigo, C., Ducasa, G., Leclercq, F., Sloan, A., Mitrofanova, A., Hashmi, T., Molina-David, J., Ge, M., Lassenius, M., Forsblom, C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85939 · Cited by 156 · see citing works

Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography–mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy

Han, L., Xia, J., Liang, Q., Wang, Y., Wang, Y., Hu, P., Li, P., & Luo, G. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.01.034 · Cited by 150 · see citing works

Cyclodextrin Protects Podocytes in Diabetic Kidney Disease

Merscher, S., Guzman, J., Pedigo, C. E., Lehto, M. J., Aguillon, R. A., Mendez, A. J., Lassenius, M. I., Forsblom, C. M., Yoo, T., Villarreal, R., et al. (2013) · Diabetes · doi:10.2337/db13-0399 · Cited by 150 · see citing works

Statins Prevent Oxidized LDL-Induced Injury of Glomerular Podocytes by Activating the Phosphatidylinositol 3-Kinase/AKT-Signaling Pathway

Bussolati, B., Deregibus, M. C., Fonsato, V., Doublier, S., Spatola, T., Procida, S., Carlo, F. D., & Camussi, G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080629 · Cited by 149 · see citing works

Oxidant stress in hyperlipidemia-induced renal damage

Scheuer, H., Gwinner, W., Hohbach, J., Gröne, E. F., Brandes, R. P., Malle, E., Olbricht, C. J., Walli, A. K., & Gröne, H. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.1.f63 · Cited by 148 · see citing works

ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis

Jao, T., Nangaku, M., Wu, C.-H., Sugahara, M., Saito, H., Maekawa, H., Ishimoto, Y., Aoe, M., Inoue, T., Tanaka, T., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.09.023 · Cited by 148 · see citing works

Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus

Pena, M. J., Heerspink, H. J. L., Hellemons, M. E., Friedrich, T., Dallmann, G., Lajer, M., Bakker, S. J. L., Gansevoort, R. T., Rossing, P. R., de Zeeuw, D., et al. (2014) · Diabetic Medicine · doi:10.1111/dme.12447 · Cited by 147 · see citing works

Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy

Choi, S. R., Lim, J. H., Kim, M. Y., Kim, E. N., Kim, Y., Choi, B. S., Kim, Y.-S., Kim, H. W., Lim, K., Kim, M.-J., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.02.004 · Cited by 147 · see citing works

Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications

Scheen, A. J. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.008 · Cited by 146 · see citing works

Systemic and renal lipids in kidney disease development and progression

WAHL, P. W., Ducasa, G. M., & Fornoni, A. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00375.2015 · Cited by 145 · see citing works

Lipotoxicity in the Pancreatic Beta Cell: Not Just Survival and Function, but Proliferation as Well?

Sharma, R. B., & Alonso, L. C. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0492-2 · Cited by 136 · see citing works

Adipocytokines and hepatic fibrosis

Saxena, N. K., & Anania, F. A. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.01.002 · Cited by 136 · see citing works

Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients

Tonolo, G., Melis, M. G., Formato, M., Angius, M. F., Carboni, A., Brizzi, P., Ciccarese, M., Cherchi, G. M., & Maioli, M. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00735.x · Cited by 135 · see citing works

Renal Lipid Metabolism and Lipotoxicity in Diabetes

Thongnak, L., Pongchaidecha, A., & Lungkaphin, A. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.11.004 · Cited by 132 · see citing works

Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy

Saraheimo, M., Forsblom, C. M., Fagerudd, J. A., Teppo, A., Pettersson-Fernholm, K., Frystyk, J., Flyvbjerg, A., Groop, P., & on behalf of the FinnDiane Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1410 · Cited by 131 · see citing works

Angiotensin 1–7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity

Mori, J., Patel, V. B., Ramprasath, T., Alrob, O. A., DesAulniers, J., Scholey, J. W., Lopaschuk, G. D., & Oudit, G. Y. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00655.2013 · Cited by 130 · see citing works

Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy

Kim, B. H., Lee, E. Y., Choi, R., Nawaboot, J., Lee, E. Y., Lee, E. Y., Kim, H. S., & Chung, C. H. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.3.664 · Cited by 130 · see citing works

Immunological evidence for hypochlorite-modified proteins in human kidney.

Malle, E., Woenckhaus, C., Waeg, G., Esterbauer, H., Gröne, E. F., & Gröne, H. (1997) · Europe PMC (PubMed Central) · Cited by 127 · see citing works

Insulin’s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion

Edgerton, D. S., Kraft, G., Smith, M. S., Farmer, B., Williams, P. E., Coate, K. C., Printz, R. L., O’Brien, R. M., & Cherrington, A. D. (2017) · JCI Insight · doi:10.1172/jci.insight.91863 · Cited by 126 · see citing works

Curcumin decreases renal triglyceride accumulation through AMPK–SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats

Soetikno, V., Sari, F. R., Sukumaran, V., Lakshmanan, A. P., Harima, M., Suzuki, K., Kawachi, H., & Watanabe, K. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.04.013 · Cited by 125 · see citing works

Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease

Jiang, T., Liebman, S. E., Lucia, M. S., Li, J., & Levi, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00733.x · Cited by 124 · see citing works

Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells

Bandet, C. L., Tan, S., Bourron, O., Stunff, H. L., & Hajduch, É. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030479 · Cited by 123 · see citing works

Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians

Afshinnia, F., Nair, V., Lin, J., Rajendiran, T. M., Soni, T., Byun, J., Sharma, K., Fort, P. E., Gardner, T. W., Looker, H. C., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130317 · Cited by 122 · see citing works

Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice

Hong, Y. A., Lim, J. H., Kim, M. Y., Kim, T. W., Kim, Y., Yang, K. S., Park, H. S., Choi, S. R., Chung, S., Kim, H. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096147 · Cited by 118 · see citing works

Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation11See Editorial by van Zonneveld and Rabelink, p. 2037

Ruan, X. Z., Varghese, Z., Powis, S. H., & Moorhead, J. F. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00025.x · Cited by 115 · see citing works

Effect of Moderate Aerobic Exercise Training on Endothelial Function and Arterial Stiffness in CKD Stages 3-4: A Randomized Controlled Trial

Van Craenenbroeck, A. H., Van Craenenbroeck, E. M., Van Ackeren, K., Vrints, C. J., Conraads, V. M., Verpooten, G. A., Kouidi, E., & Couttenye, M. M. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.03.015 · Cited by 115 · see citing works

Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome

Prieur, X., Rőszer, T., & Ricote, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.017 · Cited by 115 · see citing works

Blockade of Cannabinoid Receptor 1 Improves Insulin Resistance, Lipid Metabolism, and Diabetic Nephropathy in db/db Mice

Nam, D. H., Lee, M. H., Kim, J. E., Song, H. K., Kang, Y. S., Lee, J. E., Kim, H. W., Cha, J. J., Hyun, Y. Y., Kim, S. H., et al. (2012) · Endocrinology · doi:10.1210/en.2011-1423 · Cited by 114 · see citing works

CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice

Kang, Y. S., Lee, M., Song, H. K., Ko, G. J., Kwon, O. S., Lim, T. K., Kim, S. H., Han, S. Y., Han, K. H., Lee, J. E., et al. (2010) · Kidney International · doi:10.1038/ki.2010.263 · Cited by 112 · see citing works

Kidney Proximal Tubule Lipoapoptosis Is Regulated by Fatty Acid Transporter-2 (FATP2)

Khan, S., Cabral, P., Schilling, W. P., Schmidt, Z. W., Uddin, A. N., Gingras, A., Madhavan, S. M., Garvin, J. L., & Schelling, J. R. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030314 · Cited by 111 · see citing works

GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis

Wang, C., Li, L., Liu, S., Liao, G., Li, L., Chen, Y., Cheng, J., Lu, Y., & Liu, J. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193473 · Cited by 110 · see citing works

Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease

Kim, Y., & Park, C. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071782 · Cited by 110 · see citing works

Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis

Liu, S., Soong, Y., Seshan, S. V., & Szeto, H. H. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00697.2013 · Cited by 110 · see citing works

Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes

Nosadini, R., & Tonolo, G. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.002 · Cited by 109 · see citing works

Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease

Coughlan, M. T., & Sharma, K. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.043 · Cited by 108 · see citing works

The Coming Age of Flavonoids in the Treatment of Diabetic Complications

Caro-Ordieres, T., Marín‐Royo, G., Opazo-Ríos, L., Jiménez-Castilla, L., Moreno, J. A., Gómez‐Guerrero, C., & Egido, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020346 · Cited by 107 · see citing works

The Warburg Effect in Diabetic Kidney Disease

Zhang, G., Darshi, M., & Sharma, K. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.002 · Cited by 106 · see citing works

Podocytopathy in Diabetes: A Metabolic and Endocrine Disorder

Dı́ez-Sampedro, A., Lenz, O., & Fornoni, A. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.03.035 · Cited by 104 · see citing works

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease

Mitrofanova, A. V., Mallela, S. K., Ducasa, G. M., Yoo, T., Rosenfeld-Gur, E., Zelnik, I. D., Molina, J., Santos, J. V., Ge, M., Sloan, A. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10584-4 · Cited by 102 · see citing works

Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) Enhances Vascular and Renal Damage Induced by Hyperlipidemic Diet in ApoE-Knockout Mice

Muñoz‐García, B., Moreno, J. A., López‐Franco, Ó., Sanz, A. B., Martı́n-Ventura, J. L., Blanco, J., Jakubowski, A., Burkly, L. C., Ortíz, A., Egido, J., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.194852 · Cited by 101 · see citing works

Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy

Yiu, W. H., Li, R. X., Wong, D. W. L., Wu, H., Chan, K. W., Chan, L. Y. Y., Leung, J. C. K., Lai, K. N., Sacks, S. H., Zhou, W., et al. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx336 · Cited by 101 · see citing works

Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential

Zha, D., Wu, X., & Gao, P. H. (2017) · Endocrinology · doi:10.1210/en.2016-1765 · Cited by 100 · see citing works

Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation

Zhang, C., Shao, M., Yang, H., Chen, L., Yu, L., Cong, W., Tian, H., Zhang, F., Cheng, P., Jin, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082275 · Cited by 100 · see citing works

Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling

Guo, K., Lu, J., Huang, Y., Wu, M., Zhang, L., Yu, H., Zhang, M., Bao, Y., He, C., Chen, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125176 · Cited by 98 · see citing works

Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy

Lindblom, R. S. J., Higgins, G. C., Coughlan, M. T., & de Haan, J. B. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.134 · Cited by 98 · see citing works

Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes

Martínez-García, C., Izquierdo‐Lahuerta, A., Vivas, Y., Velasco, I., Yeo, T.-K., Chen, S., & Medina‐Gómez, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142291 · Cited by 97 · see citing works

Dyslipidemia in diabetic nephropathy

Kawanami, D., Matoba, K., & Utsunomiya, K. (2016) · Renal Replacement Therapy · doi:10.1186/s41100-016-0028-0 · Cited by 95 · see citing works

Isoquercetin upregulates antioxidant genes, suppresses inflammatory cytokines and regulates AMPK pathway in streptozotocin-induced diabetic rats

Jayachandran, M., Wu, Z., Ganesan, K., Khalid, S., Chung, S. M., & Xu, B. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.017 · Cited by 94 · see citing works

ER Stress Inhibits Liver Fatty Acid Oxidation while Unmitigated Stress Leads to Anorexia-Induced Lipolysis and Both Liver and Kidney Steatosis

DeZwaan-McCabe, D., Sheldon, R. D., Gorecki, M. C., Guo, D., Gansemer, E. R., Kaufman, R. J., Rahmouni, K., Gillum, M. P., Taylor, E. B., Teesch, L. M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.020 · Cited by 93 · see citing works

Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice

Gai, Z., Gui, T., Hiller, C., & Kullak-Ublick, G. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.694323 · Cited by 92 · see citing works

Macrophage Scavenger Receptor-A–Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation

Usui, H. K., Shikata, K., Sasaki, M., Okada, S., Matsuda, M., Shikata, Y., Ogawa, D., Kido, Y., Nagase, R., Yozai, K., et al. (2007) · Diabetes · doi:10.2337/db06-0359 · Cited by 91 · see citing works

Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes

Tofte, N., Suvitaival, T., Ahonen, L. L., Winther, S. A., Theilade, S., Frimodt‐Møller, M., Ahluwalia, T. S., & Rossing, P. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-52916-w · Cited by 88 · see citing works

Free Fatty Acids and Their Metabolism Affect Function and Survival of Podocytes

Sieber, J., & Jehle, A. W. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00186 · Cited by 88 · see citing works

Combating oxidative stress in diabetic complications with Nrf2 activators: How much is too much?

Tan, S. M., & de Haan, J. B. (2014) · Redox Report · doi:10.1179/1351000214y.0000000087 · Cited by 86 · see citing works

Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys

Tang, C., Kanter, J. E., Bornfeldt, K., LeBoeuf, R. C., & Oram, J. F. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m003525 · Cited by 85 · see citing works

Inflammatory Factors and Exercise in Chronic Kidney Disease

Dungey, M. R., Hull, K. L., Smith, A. C., Burton, J. O., & BISHOP, N. C. (2013) · International Journal of Endocrinology · doi:10.1155/2013/569831 · Cited by 85 · see citing works

Protective effect of thymol on high fat diet induced diabetic nephropathy in C57BL/6J mice

Saravanan, S., & Pari, L. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.033 · Cited by 85 · see citing works

PGC1α in the kidney

Lynch, M. R., Tran, M. T., & Parikh, S. M. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00263.2017 · Cited by 85 · see citing works

Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?

Ashcroft, F. M., Rohm, M., Clark, A., & Brereton, M. F. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.014 · Cited by 84 · see citing works

Smooth muscle cell phenotypic switch

Chaâbane, C., Coen, M., & Bochaton‐Piallat, M. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000113 · Cited by 82 · see citing works

Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum

Mori, M., Itabe, H., Higashi, Y., Fujimoto, Y., Shiomi, M., Yoshizumi, M., Ouchi, Y., & Takano, T. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31503-0 · Cited by 82 · see citing works

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes

Gastaldelli, A., Repetto, E., Guja, C., Hardy, E., Han, J., Jabbour, S. A., & Ferrannini, E. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13907 · Cited by 81 · see citing works

Glucose and glycogen in the diabetic kidney: Heroes or villains?

Sullivan, M. A., & Forbes, J. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.067 · Cited by 81 · see citing works

Lipotoxicity in renal proximal tubular cells: Relationship between endoplasmic reticulum stress and oxidative stress pathways

Katsoulieris, E. N., Mabley, J. G., Samai, M. H., Sharpe, M. A., Green, I. C., & Chatterjee, P. K. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.021 · Cited by 80 · see citing works

Endothelial Fatty Acid Transport: Role of Vascular Endothelial Growth Factor B

Hagberg, C. E., Mehlem, A., Falkevall, A., Muhl, L., & Eriksson, U. (2013) · Physiology · doi:10.1152/physiol.00042.2012 · Cited by 78 · see citing works

Advanced Oxidation Protein Products Activate Intrarenal Renin–Angiotensin System via a CD36-Mediated, Redox-Dependent Pathway

Cao, W., Xu, J., Zhou, Z. M., Wang, G. B., Hou, F. F., & Nie, J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4603 · Cited by 77 · see citing works

Monocytes and macrophages as protagonists in vascular complications of diabetes

Kanter, J. E., Hsu, C.-C., & Bornfeldt, K. E. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00010 · Cited by 76 · see citing works

Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels

Rydén, M., & Arner, P. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309759 · Cited by 75 · see citing works

Saturated free fatty acids and apoptosis in microvascular mesangial cells: palmitate activates pro-apoptotic signaling involving caspase 9 and mitochondrial release of endonuclease G

Mishra, R., & Simonson, M. S. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-2 · Cited by 73 · see citing works

Albumin-bound fatty acids but not albumin itself alter redox balance in tubular epithelial cells and induce a peroxide-mediated redox-sensitive apoptosis

Ruggiero, C., Elks, C. M., Kruger, C., Cleland, E., Addison, K., Noland, R. C., & Stadler, K. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00484.2013 · Cited by 73 · see citing works

Underlying Mechanisms of Renal Lipotoxicity in Obesity

Escasany, E., Izquierdo‐Lahuerta, A., & Medina‐Gómez, G. (2019) · The Nephron journals/Nephron journals · doi:10.1159/000494694 · Cited by 73 · see citing works

Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells

Iwai, T., Kume, S., Chin‒Kanasaki, M., Kuwagata, S., Araki, H., Takeda, N., Sugaya, T., Uzu, T., Maegawa, H., & Araki, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111868 · Cited by 72 · see citing works

Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy

Ritchie, R. H., Zerenturk, E. J., Prakoso, D., & Calkin, A. C. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0249 · Cited by 72 · see citing works

Lipid Droplet Accumulation Is Associated with an Increase in Hyperglycemia-Induced Renal Damage

Kiss, É., Kränzlin, B., Wagenblaβ, K., Bonrouhi, M., Thiery, J., Gröne, E. F., Nordström, V., Teupser, D., Gretz, N., Malle, E., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.033 · Cited by 68 · see citing works

Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy

Jiang, X., Yu, J., Wang, X., Ge, J., & Li, N. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s195456 · Cited by 68 · see citing works

The Fatty Kidney: Obesity and Renal Disease

Praga, M., & Morales, E. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447674 · Cited by 67 · see citing works

Anthocyanin-rich Seoritae extract ameliorates renal lipotoxicity via activation of AMP-activated protein kinase in diabetic mice

Koh, E. S., Lim, J. H., Kim, M. Y., Chung, S., Shin, S. J., Choi, B. S., Kim, H. W., Hwang, S. Y., Kim, S. W., Park, C. W., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0563-4 · Cited by 67 · see citing works

Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice

Yin, Q., Zhang, R., Li, L., Wang, Y.-T., Liu, J., Zhang, J., Bai, L., Cheng, J., Fu, P., & Liu, F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730564 · Cited by 66 · see citing works

Association between Plasma Nonesterified Fatty Acids Species and Adipose Tissue Fatty Acid Composition

Hellmuth, C., Demmelmair, H., Schmitt, I., Peißner, W., Blüher, M., & Koletzko, B. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074927 · Cited by 66 · see citing works

Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors

Pereira, M. J., Skrtic, S., Katsogiannos, P., Abrahamsson, N., Sidibeh, C. O., Dahgam, S., Månsson, M., Risérus, U., Kullberg, J., & Eriksson, J. W. (2016) · Metabolism · doi:10.1016/j.metabol.2016.09.008 · Cited by 65 · see citing works

The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis

Zhang, Z., Wu, P., Zhang, J., Wang, S., & Zhang, G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.005 · Cited by 65 · see citing works

Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 11/2 years

Bosmans, J., Holvoet, P., Dauwe, S. E. H., Ysebaert, D., Chapelle, T., Jürgens, A., Kovacic, V., Marck, E. A. V., Broe, M. E. D., & Verpooten, G. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00752.x · Cited by 65 · see citing works

Exercise counteracts lipotoxicity by improving lipid turnover and lipid droplet quality

Zacharewicz, E., Hesselink, M. K. C., & Schrauwen, P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12729 · Cited by 63 · see citing works

Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics

Manco, M. (2017) · Children · doi:10.3390/children4080074 · Cited by 63 · see citing works

Cellular Cholesterol Transport Proteins in Diabetic Nephropathy

Tsun, J. G., Yung, S., Chau, M. K. M., Shiu, S. W. M., Chan, T. M., & Tan, K. C. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105787 · Cited by 62 · see citing works

Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro

Hafiane, A., Bielicki, J. K., Johansson, J. O., & Genest, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131997 · Cited by 61 · see citing works

Role of PPARγ in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential

Yang, J., Zhang, D., Li, J., Zhang, X., Fan, F., & Guan, Y. (2008) · Clinical Science · doi:10.1042/cs20070462 · Cited by 61 · see citing works

PGC-1α Coordinates Mitochondrial Respiratory Capacity and Muscular Fatty Acid Uptake via Regulation of VEGF-B

Mehlem, A., Palombo, I., Wang, X., Hagberg, C. E., Eriksson, U., & Falkevall, A. (2016) · Diabetes · doi:10.2337/db15-1231 · Cited by 60 · see citing works

Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy

Xiao, L., Zhang, T., Geng, J., Wu, Z., Xu, L., Liu, J., Tian, J., Zhou, Z., Nie, J., & Bai, X. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7634 · Cited by 60 · see citing works

Hyperlipidemia-Associated Renal Damage Decreases Klotho Expression in Kidneys from ApoE Knockout Mice

Sastre, C., Rubio‐Navarro, A., Buendía, I., Gómez‐Guerrero, C., Blanco, J., Mas, S., Egido, J., Blanco‐Colio, L. M., Ortíz, A., & Moreno, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083713 · Cited by 60 · see citing works

New Era of Lipid-Lowering Drugs

Barter, P. J., & Rye, K. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012203 · Cited by 59 · see citing works

Susceptibility of Podocytes to Palmitic Acid Is Regulated by Stearoyl-CoA Desaturases 1 and 2

Sieber, J., Weins, A., Kampe, K., Gruber, S., Lindenmeyer, M. T., Cohen, C. D., Orellana, J. M., Mundel, P. H., & Jehle, A. W. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.023 · Cited by 59 · see citing works

Macrophage Functions in Atherosclerosis

Zeller, I., & Srivastava, S. (2014) · Circulation Research · doi:10.1161/circresaha.114.305641 · Cited by 56 · see citing works

Abnormal HDL Apolipoprotein A-I and A-II Kinetics in Hemodialysis Patients

Okubo, K., Ikewaki, K., Sakai, S., Tada, N., Kawaguchi, Y., & Mochizuki, S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000117286.85443.7d · Cited by 56 · see citing works

Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort

Taylor, R., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Sattar, N., Welsh, P., Peters, C., Zhyzhneuskaya, S., et al. (2018) · Diabetologia · doi:10.1007/s00125-017-4503-0 · Cited by 55 · see citing works

Role of oxidized low-density lipoprotein in the atherosclerosis of uremia

Drüeke, T. B., Nguyen‐Khoa, T., Massy, Z. A., Witko‐Sarsat, V., Lacour, B., & Descamps‐Latscha, B. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780114.x · Cited by 55 · see citing works

Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules

Hosokawa, K., Takata, T., Sugihara, T., Matono, T., Koda, M., Kanda, T., Taniguchi, S., Ida, A., Mae, Y., Yamamoto, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010190 · Cited by 54 · see citing works

Low cardiac lipolysis reduces mitochondrial fission and prevents lipotoxic heart dysfunction in Perilipin 5 mutant mice

Kolleritsch, S., Kien, B., Schoiswohl, G., Diwoky, C., Schreiber, R., Heier, C., Maresch, L. K., Schweiger, M., Eichmann, T. O., Stryeck, S., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz119 · Cited by 54 · see citing works

Albumin contributes to kidney disease progression in Alport syndrome

Jarad, G., Knutsen, R. H., Mecham, R. P., & Miner, J. H. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00456.2015 · Cited by 54 · see citing works

Impact of Treatment of Dyslipidemia on Renal Function, Fat Deposits and Scarring in Patients with Persistent Nephrotic Syndrome

Gheith, O. A. A., Sobh, M. A. K., Mohamed, K. E.-S., El-Baz, M. A., El-Husseini, F., Gazarin, S. S., Ahmed, H. A.-E.-H., Rasem, M. W., & Amer, G. M. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000065021 · Cited by 53 · see citing works

Metabolism, Energetics, and Lipid Biology in the Podocyte – Cellular Cholesterol-Mediated Glomerular Injury

Merscher, S., Pedigo, C. E., & Mendez, A. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00169 · Cited by 52 · see citing works

SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis

Wang, T. N., Chen, X., Li, R., Gao, B., Mohammed‐Ali, Z., Lü, C., Yum, V., Dickhout, J. G., & Krepinsky, J. C. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121332 · Cited by 51 · see citing works

Serum Adiponectin and Renal Dysfunction in Men With Type 2 Diabetes

Lin, J., Hu, F. B., & Curhan, G. C. (2007) · Diabetes Care · doi:10.2337/dc06-1296 · Cited by 51 · see citing works

The crucial role and mechanism of insulin resistance in metabolic disease

Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 630 · see citing works

Signaling pathways of chronic kidney diseases, implications for therapeutics

Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 477 · see citing works

Targeting inflammation to treat diabetic kidney disease: the road to 2030

Rayego‐Mateos, S., Rodrigues-Díez, R. R., Fernández‐Fernández, B., Fernández, C. M., Marchant, V. A., Donate‐Correa, J., Navarro‐González, J. F., Ortíz, A., & Ruiz‐Ortega, M. (2022) · Kidney International · doi:10.1016/j.kint.2022.10.030 · Cited by 376 · see citing works

Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathy

Jiang, W., Xu, C., Du, C., Dong, J., Xu, S., Hu, B.-F., Feng, R., Zang, D., Meng, X., Huang, C., et al. (2021) · Theranostics · doi:10.7150/thno.63735 · Cited by 188 · see citing works

Mitochondrial metabolic reprogramming in diabetic kidney disease

Fan, X., Yang, M., Lang, Y., Lu, S., Kong, Z., Gao, Y., Shen, N., Zhang, D., & Lv, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06833-0 · Cited by 158 · see citing works

Roles and crosstalks of macrophages in diabetic nephropathy

Li, H.-D., You, Y., Shao, B., Wu, W., Wang, Y.-F., Guo, J.-B., Meng, X., & Chen, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1015142 · Cited by 134 · see citing works

Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects

Li, X., Zhang, Y., Xing, X., Mi, L., Liu, Y., Xu, A., & Zhang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115670 · Cited by 139 · see citing works

Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney

Hou, Y., Tan, E., Shi, H., Ren, X., Wan, X., Wu, W., Chen, Y., Niu, H., Zhu, G., Li, J., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05078-y · Cited by 127 · see citing works

Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy

Han, Y., Xiong, S., Zhao, H., Yang, S., Yang, M., Zhu, X., Jiang, N., Xiong, X., Gao, P., Wei, L., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04326-y · Cited by 120 · see citing works

Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis

Dai, Y., Quan, J., Xiong, L., Luo, Y., & Yi, B. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2079522 · Cited by 115 · see citing works

Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications

Yang, X., & Yang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.853822 · Cited by 105 · see citing works

Programmed Cell Death in Diabetic Nephropathy: A Review of Apoptosis, Autophagy, and Necroptosis

Erekat, N. S. (2022) · Medical Science Monitor · doi:10.12659/msm.937766 · Cited by 97 · see citing works

The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospects

Ren, L., Cui, H., Wang, Y., Ju, F., Cai, Y., Gang, X., & Wang, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114465 · Cited by 99 · see citing works

Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy

Zhou, Y., Liu, L., Jin, B., Wu, Y., Xu, L., Chang, X., Hu, L., Wang, G., Huang, Y., Song, L., et al. (2023) · Diabetes · doi:10.2337/db22-0680 · Cited by 91 · see citing works

100 th anniversary of the discovery of insulin perspective: insulin and adipose tissue fatty acid metabolism

Carpentier, A. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00620.2020 · Cited by 89 · see citing works

Relationship Between the TyG Index and Diabetic Kidney Disease in Patients with Type-2 Diabetes Mellitus

Lv, L., Zhou, Y., Chen, X., Gong, L., Wu, J., Luo, W., Shen, Y., Han, S., Hu, J., Wang, Y., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s318255 · Cited by 86 · see citing works

Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease

Czaja-Stolc, S., Potrykus, M., Stankiewicz, M., Kaska, Ł., & Małgorzewicz, S. (2022) · Nutrients · doi:10.3390/nu14071457 · Cited by 85 · see citing works

Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway

Lv, C., Cheng, T., Zhang, B., Sun, K., & Lu, K. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2165103 · Cited by 83 · see citing works

Glucose and glycogen in the diabetic kidney: Heroes or villains?

Sullivan, M. A., & Forbes, J. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.067 · Cited by 81 · see citing works

Diabetes and its complications: molecular mechanisms, prevention and treatment

Zhao, L., Yuan, J., Yang, Q., Ma, J., Yang, F., Zou, Y., Liu, K., & Liu, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02401-w · Cited by 80 · see citing works

Interplay of lipid metabolism and inflammation in podocyte injury

Luo, Z., Chen, Z., Hu, J., & Ding, G. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155718 · Cited by 74 · see citing works

Insulin Resistance, Obesity, and Lipotoxicity

Yazıcı, D., Demir, S. Ç., & Sezer, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_14 · Cited by 76 · see citing works

The effect of quercetin on diabetic nephropathy (DN): a systematic review and meta-analysis of animal studies

Hu, T., Yue, J., Tang, Q., Cheng, K., Chen, F., Peng, M., Zhou, Q., & Wang, M. (2022) · Food & Function · doi:10.1039/d1fo03958j · Cited by 67 · see citing works

Significance of Metformin Use in Diabetic Kidney Disease

Kawanami, D., Takashi, Y., & Tanabe, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124239 · Cited by 62 · see citing works

Berberine Reduces Lipid Accumulation by Promoting Fatty Acid Oxidation in Renal Tubular Epithelial Cells of the Diabetic Kidney

Rong, Q., Han, B., Li, Y., Yin, H., Li, J., & Hou, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.729384 · Cited by 59 · see citing works

New Pandemic: Obesity and Associated Nephropathy

Sharma, I., Liao, Y., Zheng, X., & Kanwar, Y. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.673556 · Cited by 57 · see citing works

Renoprotective Effects of DPP-4 Inhibitors

Kawanami, D., Takashi, Y., Takahashi, H., Motonaga, R., & Tanabe, M. (2021) · Antioxidants · doi:10.3390/antiox10020246 · Cited by 57 · see citing works

The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease

Sun, Y., Cui, S., Hou, Y., & Yi, F. (2021) · Kidney Diseases · doi:10.1159/000518132 · Cited by 54 · see citing works

Functions of Stress-Induced Lipid Droplets in the Nervous System

Islimye, E., Girard, V., & Gould, A. P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.863907 · Cited by 55 · see citing works

The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes

Chen, X., Shi, C., Wang, Y., Yu, H., Zhang, Y., Zhang, J., Li, P., & Gao, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.952445 · Cited by 54 · see citing works

Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease

Guo, X., Si, W., Wang, J., Zeng, X., Yu, H., Chen, Y., Zhu, X., & Li, X. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155705 · Cited by 51 · see citing works

Fatty kidney disease: The importance of ectopic fat deposition and the potential value of imaging

Mende, C. W., & EINHORN, D. F. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13232 · Cited by 49 · see citing works

Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis

Liu, H.-J., Miao, H., Yang, J.-Z., Liu, F., Cao, G., & Zhao, Y. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101861 · Cited by 49 · see citing works

Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease

Nicholson, R. J., Pezzolesi, M. G., & Summers, S. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.622692 · Cited by 49 · see citing works

B cell-derived anti-beta 2 glycoprotein I antibody mediates hyperhomocysteinemia-aggravated hypertensive glomerular lesions by triggering ferroptosis

Du, X., Ma, X., Tan, Y., Shao, F., Li, C., Zhao, Y., Miao, Y., Han, L., Dang, G., Song, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01313-x · Cited by 49 · see citing works

Identification and validation of immune and cuproptosis - related genes for diabetic nephropathy by WGCNA and machine learning

Chen, Y., Liao, L., Wang, B., & Wu, Z. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1332279 · Cited by 48 · see citing works

Lipotoxic Proximal Tubular Injury: A Primary Event in Diabetic Kidney Disease

Wang, H., Zhang, S., & Guo, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.751529 · Cited by 45 · see citing works

Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity

Marrano, N., Biondi, G., Borrelli, A., Rella, M., Zambetta, T., Gioia, L. D., Caporusso, M., Logroscino, G., Perrini, S., Giorgino, F., et al. (2023) · Biomolecules · doi:10.3390/biom13010183 · Cited by 44 · see citing works

Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities

Lin, P., & Duann, P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01050 · Cited by 45 · see citing works

Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway

Gu, W., Wang, X., Zhao, H., Geng, J., Li, X., Zheng, K., Guan, Y., Hou, X., Wang, C., & Song, G. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174776 · Cited by 44 · see citing works

Advances in energy metabolism in renal fibrosis

Wei, X. S., Hou, Y., Long, M., Jiang, L., & Du, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121033 · Cited by 44 · see citing works

Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway

Lu, J., Li, X., Chen, P., Zhang, J.-X., Li, L., Wang, G., Liu, X.-Q., Jiang, C., & Ma, K. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01160-0 · Cited by 42 · see citing works

Diosgenin protects against podocyte injury in early phase of diabetic nephropathy through regulating SIRT6

Wang, Z., Wu, Q., Wang, H., Gao, Y., Nie, K., Tang, Y., Su, H., Hu, M., Gong, J., Fang, K., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154276 · Cited by 42 · see citing works

Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy

Li, W., Sun, J., Zhou, X., Lu, Y., Cui, W., & Miao, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.780790 · Cited by 38 · see citing works

CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease

Wang, X., Song, M., Li, X., Su, C., Yang, Y., Wang, K., Liu, C., Zheng, Z., Jia, Y., Ren, S., et al. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00144.2023 · Cited by 38 · see citing works

Molecular mechanism of renal lipid accumulation in diabetic kidney disease

Fang, Z., Liu, R., Xie, J., & He, C. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18364 · Cited by 38 · see citing works

The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes

Ji, X., Zhang, W., Yin, L., Shi, Z., Luan, J., Chen, L., & Liu, L. (2022) · Biomolecules · doi:10.3390/biom12121832 · Cited by 37 · see citing works

Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets

Zhong, S., Wang, N., & Zhang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169035 · Cited by 43 · see citing works

Lipid abnormality in diabetic kidney disease and potential treatment advancements

Tu, Q. M., Jin, H. M., & Yang, X. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1503711 · Cited by 37 · see citing works

The cholesterol‐HDL‐glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy

Çatak, M., Konuk, Ş. G., & Hepşen, S. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70086 · Cited by 37 · see citing works

Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control

Takata, T., & Isomoto, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094374 · Cited by 37 · see citing works

The ability of microRNAs to regulate the immune response in ischemia/reperfusion inflammatory pathways

Artimovič, P., Špaková, I., Macejková, E., Pribulová, T., Rabajdová, M., Mareková, M., & Závacká, M. (2024) · Genes and Immunity · doi:10.1038/s41435-024-00283-6 · Cited by 36 · see citing works

The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies

Giardini, E., Moore, D., Sadlier, D. M., Godson, C., & Brennan, E. P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118615 · Cited by 36 · see citing works

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus

Dejenie, T. A., Abebe, E. C., Mengstie, M. A., Seid, M. A., Gebeyehu, N. A., Adella, G. A., Kassie, G. A., Gebrekidan, A. Y., Gesese, M. M., Tegegne, K. D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1124367 · Cited by 38 · see citing works

Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice

Zhao, J., He, K., Du, H., Wei, G., Wen, Y., Wang, J., Zhou, X., & Wang, J. (2022) · PeerJ · doi:10.7717/peerj.13932 · Cited by 34 · see citing works

Morroniside attenuates podocytes lipid deposition in diabetic nephropathy: A network pharmacology, molecular docking and experimental validation study

Chen, Y., Chen, M., Zhu, W., Zhang, Y., Liu, P., & Li, P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112560 · Cited by 34 · see citing works

Role of sex hormones in diabetic nephropathy

Liu, J., Liu, Z., Sun, W., Luo, L., An, X., Yu, D., & Wang, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1135530 · Cited by 34 · see citing works

Nephropathy Is Aggravated by Fatty Acids in Diabetic Kidney Disease through Tubular Epithelial Cell Necroptosis and Is Alleviated by an RIPK-1 Inhibitor

Yu, Q., Chen, Y., Zhao, Y., Huang, S., Xin, X., Jiang, L., Wang, H., Wu, W., Qu, L., Xiang, C., et al. (2023) · Kidney Diseases · doi:10.1159/000529995 · Cited by 33 · see citing works

Inhibition of Fatty Acid β-Oxidation by Fatty Acid Binding Protein 4 Induces Ferroptosis in HK2 Cells Under High Glucose Conditions

Chen, J., Wu, K., Yan, L., Huang, M., Cheng, L., Guan, H., Lin, J., Zhong, M., Wang, X., & Zheng, Z. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1604 · Cited by 33 · see citing works

The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review

Iordan, L., Gaiţă, L., Timar, R. Z., Avram, V. F., Sturza, A., & Timar, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137057 · Cited by 33 · see citing works

Tubular Mas receptor mediates lipid-induced kidney injury

Kong, Y., Zhao, X., Qiu, M., Lin, Y., Feng, P., Li, S., Liang, B., Zhu, Q., Huang, H., Li, C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03375-z · Cited by 33 · see citing works

Regulation of renal lipid deposition in diabetic nephropathy on morroniside via inhibition of NF-KB/TNF-a/SREBP1c signaling pathway

Zhu, W., Chen, M., Wang, Y., Chen, Y., Zhang, Y., Wang, Y., Liu, P., & Li, P. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110711 · Cited by 33 · see citing works

The Potential Effects of Dietary Antioxidants in Obesity: A Comprehensive Review of the Literature

Almoraie, N. M., & Shatwan, I. M. (2024) · Healthcare · doi:10.3390/healthcare12040416 · Cited by 32 · see citing works

Long non-coding RNA CDKN2B-AS1 regulates high glucose-induced human mesangial cell injury via regulating the miR-15b-5p/WNT2B axis

Chang, J., Yu, Y., Fang, Z., He, H., Wang, D., Teng, J., & Yang, L. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00618-z · Cited by 32 · see citing works

Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease

Jiang, S., & Su, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01323-w · Cited by 33 · see citing works

LncRNA H19: a novel player in the regulation of diabetic kidney disease

Wu, Q., & Huang, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1238981 · Cited by 31 · see citing works

CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo

Xie, Y., Yuan, Q., Tang, B., Xie, Y., Cao, Y., Qiu, Y., Zeng, J., Wang, Z., Su, H., & Zhang, C. (2024) · Diabetes · doi:10.2337/db23-0811 · Cited by 31 · see citing works

Effects of dietary polyphenols in the glycemic, renal, inflammatory, and oxidative stress biomarkers in diabetic nephropathy: a systematic review with meta-analysis of randomized controlled trials

Macêna, M. D. L., Nunes, L. F. D. S., da Silva, A. F., Pureza, I. R. D. O. M., Praxedes, D. R. S., Santos, J. C. D. F., & Bueno, N. B. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac035 · Cited by 28 · see citing works

Activation of PAR2 promotes high-fat diet-induced renal injury by inducing oxidative stress and inflammation

Ha, S., Yang, Y., Kim, B. M., Kim, J., Son, M., Kim, D., Yu, H. S., Im, D., Chung, H. Y., & Chung, K. W. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166474 · Cited by 28 · see citing works

Dibenzoylmethane ameliorates lipid-induced inflammation and oxidative injury in diabetic nephropathy

Lee, E. Y., Kwon, M.-H., Kim, H. M., Kim, N., Kim, Y. M., Kim, H. S., Lee, E. Y., & Chung, C. H. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0206 · Cited by 28 · see citing works

Effect and pharmacological mechanism of Salvia miltiorrhiza and its characteristic extracts on diabetic nephropathy

Cai, L.-Q., Chen, Y., Xue, H., Yang, Y., Wang, Y., Xu, J., Zhu, C., He, L., & Xiao, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117354 · Cited by 27 · see citing works

Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway

Xiao, Y., Deng, J., Li, C., Gong, X., Gui, Z., Huang, J., Zhang, Y., Liu, Y., Ye, X., & Li, X. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153488 · Cited by 27 · see citing works

Piceatannol promotes hepatic and renal AMPK/SIRT1/PGC-1α mitochondrial pathway in rats exposed to reserpine or gamma-radiation

Moustafa, E. M., Rashed, E. R., Rashed, R. R., & Omar, N. N. (2021) · International Journal of Immunopathology and Pharmacology · doi:10.1177/20587384211016194 · Cited by 27 · see citing works

Transforming growth factor β3 deficiency promotes defective lipid metabolism and fibrosis in murine kidney

Escasany, E., Lanzón, B., García-Carrasco, A., Izquierdo‐Lahuerta, A., Torres, L., Corrales, P., Rodríguez‐Rodríguez, A. E., Lima, S. L., Martínez‐Álvarez, C., Rupérez, F. J., et al. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048249 · Cited by 27 · see citing works

Exposure to low dose of Bisphenol A (BPA) intensifies kidney oxidative stress, inflammatory factors expression and modulates Angiotensin II signaling under hypertensive milieu

Nagarajan, M., Maadurshni, G. B., & Manivannan, J. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23533 · Cited by 27 · see citing works

Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response

Cao, Z., Zhao, H., Fan, J., Shen, Y., Han, L., Jing, G., Zeng, X. L., Jin, X., Zhu, Z., Bian, Q., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01304-5 · Cited by 26 · see citing works

Impact of baseline and trajectory of the atherogenic index of plasma on incident diabetic kidney disease and retinopathy in participants with type 2 diabetes: a longitudinal cohort study

Zhang, J. Y., Liu, C., Peng, Y. H., Fang, Q., Wei, X., Zhang, C., Sun, L., Hu, Z., Hong, J., Gu, W., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02003-5 · Cited by 25 · see citing works

Chlorogenic acid alleviates renal fibrosis by reducing lipid accumulation in diabetic kidney disease through suppressing the Notch1 and Stat3 signaling pathway

Yang, X., Jiang, D., Wang, Y.-Z., Duan, M.-Y., Huang, Y., Wang, X., Xiang, Z.-M., Sheng, J., & Zhu, Q. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2371988 · Cited by 25 · see citing works

Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms

Liu, K., Zhao, X., Qi, X., Hou, D.-L., Li, H.-B., Gu, Y., & Xu, Q. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113388 · Cited by 25 · see citing works

Intermittent Fasting—A Healthy Dietary Pattern for Diabetic Nephropathy

Yang, M., Chen, W., He, L., Liu, D., Zhao, L., & Wang, X. (2022) · Nutrients · doi:10.3390/nu14193995 · Cited by 25 · see citing works

ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders

Cao, X., Song, L., & Yang, J. (2021) · Clinical Science · doi:10.1042/cs20200752 · Cited by 24 · see citing works

Fatty kidney: A possible future for chronic kidney disease research

Kanbay, M., Çöpür, S., Demiray, A., Sag, A. A., Covic, A. C., Ortíz, A., & Tuttle, K. R. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13748 · Cited by 24 · see citing works

Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway

Zhang, Y., Yao, H., Li, C., Sun, W., Chen, X., Cao, Y. W., Liu, Y., Liu, Y., Chen, J., Qi, J., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6275505 · Cited by 24 · see citing works

The Roles of Fatty Acids and Apolipoproteins in the Kidneys

Pan, X. (2022) · Metabolites · doi:10.3390/metabo12050462 · Cited by 27 · see citing works

Sirtuin 3 Deficiency Aggravates Kidney Disease in Response to High-Fat Diet through Lipotoxicity-Induced Mitochondrial Damage

Locatelli, M., Macconi, D., Corna, D., Cerullo, D., Rottoli, D., Remuzzi, G., Benigni, A., & Zoja, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158345 · Cited by 26 · see citing works

Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes

Opazo-Ríos, L., Matus, Y. S., Rodrigues-Díez, R. R., Carpio, D., Droguett, A., Egido, J., Gómez‐Guerrero, C., & Mezzano, S. A. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001242 · Cited by 24 · see citing works

The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?

Tramontano, D., D'Erasmo, L., Larouche, M., Brisson, D., Lauzière, A., Di Costanzo, A., Bini, S., Minicocci, I., Covino, S., Baratta, F., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119146 · Cited by 23 · see citing works

Fenofibrate Attenuates Renal Tubular Cell Apoptosis by Up-Regulating MCAD in Diabetic Kidney Disease

Tang, C., Deng, X., Qu, J., Miao, Y., Tian, L., Zhang, M., Li, X., Sun, B., & Chen, L. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s405266 · Cited by 22 · see citing works

Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies

Yu, W., Haoyu, Y., Ling, Z., Xing, H., Pengfei, X., Anzhu, W., Lili, Z., & Linhua, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1549484 · Cited by 22 · see citing works

Tubular Injury in Diabetic Kidney Disease: Early Diagnosis and Intervention Strategies

Lv, Y., Ye, C., Li, Z., Ye, J., Cao, H., Zhang, C., Jiang, H., & Wang, Y. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70098 · Cited by 26 · see citing works

Association between LXR-α and ABCA1 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus in a Chinese Han Population

Liu, P., Ma, L., Zhao, H., Shen, Z., Zhou, X., Yan, M., Zhao, T., Zhang, H., Qiu, X., & Li, P. (2020) · Journal of Diabetes Research · doi:10.1155/2020/8721536 · Cited by 22 · see citing works

GLP-1-Induced AMPK Activation Inhibits PARP-1 and Promotes LXR-Mediated ABCA1 Expression to Protect Pancreatic β-Cells Against Cholesterol-Induced Toxicity Through Cholesterol Efflux

Li, R., Sun, X., Li, P., Li, W., Zhao, L., Zhu, L., & Zhu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.646113 · Cited by 22 · see citing works

The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy

Li, Z., Yang, W., Yang, Y., Wu, J., Luo, P., & Liu, Y. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s346546 · Cited by 22 · see citing works

Predictive Value of Plasma Atherogenic Index for Microalbuminuria in Newly Diagnosed Patients with Type 2 Diabetes Mellitus

Qi, L., Kang, N., Chen, X., Li, Z., Deng, C., & Chen, S. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s359811 · Cited by 21 · see citing works

Natural Product Skatole Ameliorates Lipotoxicity-Induced Multiple Hepatic Damage under Hyperlipidemic Conditions in Hepatocytes

Hong, S., Hong, Y., Lee, M., Keum, B., & Kim, G. (2023) · Nutrients · doi:10.3390/nu15061490 · Cited by 21 · see citing works

Protective effects and possible mechanisms of catalpol against diabetic nephropathy in animal models: a systematic review and meta-analysis

Fu, Z., Su, X., Zhou, Q., Feng, H., Ding, R., & Ye, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1192694 · Cited by 21 · see citing works

Exploring the Genetic Conception of Obesity via the Dual Role of FoxO

Behl, T., Kaur, I., Sehgal, A., Singh, S., Zengin, G., Negruţ, N., Nistor-Cseppento, C. D., Pavel, F. M., Aron, R. A. C., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063179 · Cited by 22 · see citing works

Role of CD36 in Palmitic Acid Lipotoxicity in Neuro-2a Neuroblastoma Cells

Urso, C. J., & Zhou, H. (2021) · Biomolecules · doi:10.3390/biom11111567 · Cited by 21 · see citing works

Circadian light/dark cycle reversal exacerbates the progression of chronic kidney disease in mice

Zhang, J., Qiu, L.-J., Liu, Z., Liu, J., Yu, B., Liu, C., Ren, B., Zhang, J., Li, S., Guan, Y., et al. (2024) · Journal of Pineal Research · doi:10.1111/jpi.12964 · Cited by 20 · see citing works

Obesity: The Fat Tissue Disease Version of Cancer

Boubertakh, B., Silvestri, C., & Marzo, V. D. (2022) · Cells · doi:10.3390/cells11121872 · Cited by 20 · see citing works

Renal Lipid Metabolism and Lipotoxicity in Diabetes

Thongnak, L., Pongchaidecha, A., & Lungkaphin, A. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.11.004 · Cited by 132 · see citing works

Renal Lipotoxicity: Mechanisms and Therapeutic Perspectives

Zaitoon, H., Feigin, E., Abdul‐Ghani, M. A., Clarke, G. D., Tuttle, K. R., & DeFronzo, R. A. (2026) · Diabetes Care · doi:10.2337/dci26-0036 · Cited by 4 · see citing works

Normal nerve conduction with an abnormal ultrasound: A separate group of CTS?

Wilder-Smith, E. P., & Sebastin, S. J. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.008 · Cited by 2 · see citing works

The Role of Lipotoxicity in Diabetic Nephropathy: From Physiologic Mechanisms to Therapeutic Perspectives

范, 家. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541172

The Contribution of Lipotoxicity to Diabetic Kidney Disease

Schelling, J. R. (2022) · Cells · doi:10.3390/cells11203236 · Cited by 86 · see citing works